Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2025 | 04-2024 | 04-2023 | 04-2022 | 04-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,701 | -7,276 | -5,335 | 548 | 362 |
| Depreciation Amortization | 1,640 | 1,867 | 2,246 | 1,627 | 1,184 |
| Income taxes - deferred | -181 | N/A | N/A | N/A | N/A |
| Accounts receivable | -1,436 | -1,991 | 1,308 | -2,818 | -2,265 |
| Accounts payable and accrued liabilities | -1,749 | 465 | 2,465 | 974 | -1,246 |
| Other Working Capital | -621 | -3,823 | 4,243 | 2,336 | -4,197 |
| Other Operating Activity | 5,032 | 4,621 | -955 | 3,830 | 4,481 |
| Operating Cash Flow | $7,386 | $-6,137 | $3,972 | $6,497 | $-1,681 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -389 | -836 | -2,872 | -2,384 | -3,281 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 112 |
| Investing Cash Flow | $-389 | $-836 | $-2,872 | $-2,384 | $-3,169 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -150 | -146 | N/A | N/A | -174 |
| Common Stock Issued | 320 | 253 | 85 | 207 | 1,369 |
| Common Stock Repurchased | N/A | -634 | -74 | N/A | N/A |
| Financing Cash Flow | $170 | $-527 | $11 | $207 | $1,195 |
| Beginning Cash Position | 2,618 | 10,118 | 9,007 | 4,687 | 8,342 |
| End Cash Position | 9,785 | 2,618 | 10,118 | 9,007 | 4,687 |
| Net Cash Flow | $7,167 | $-7,500 | $1,111 | $4,320 | $-3,655 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,386 | -6,137 | 3,972 | 6,497 | -1,681 |
| Capital Expenditure | -389 | -836 | -2,872 | -2,384 | -3,281 |
| Free Cash Flow | 6,997 | -6,973 | 1,100 | 4,113 | -4,962 |